Faculty of Sport Sciences
Granada, 18071, Spain
NCT Number: NCT01940627
The General Aim of this study is to verify if a short term supplementation can modulate diverse aspects related to the physical regular high intensity activity. To get this general aim and following the criteria established by the EFSA Guides, this general aim will be divided in specific or concrete aims, and will be studied by its specific analytical.
First Specific Aim: To study how the supplementation with 200 mg of ubiquinol in a short term (2 weeks) study can influence the physical performance, resitance , muscle function and weakening: maintenance of normal muscle function, maintenance of endurance performance, increase in endurance performance/capacity, reduction in the rated perceived exertion/effort during exercise, increase in physical performance and maintenance of muscle mass and piscological variables that the sportsman suffers before and after the high intensity exercise.
Second Specific Aim: To study how the supplementation with 200 mg of ubiquinol in a short term (2 weeks) study can influence the biochemical and haematological parameters in sportsman.
Third Specific Aim: To study how the supplementation with 200 mg of ubiquinol in a short term (2 weeks) study can influence the oxidative stress asociated to a high intensity exercise.
Fourth Specific Aim: To study how the supplementation with 200 mg of ubiquinol in a short term (2 weeks) study can influence the inflammatory signaling, the activity of diverse pro - and anti-inflammatory citokines associated to high intensity exercise.
Looking for future studies?
Notify Me31 year–45 year
Male
Interventional
Phase 2 / Phase 3
Granada, 18071, Spain
3.1.- SUBJECTS This is a randomized, controled, double blind trial. The experimental subjects that will take part in this study are Spanish Fire Department. We will try to get a total sample of 100 subjects on each study to constitute two groups of 50 subjects, one experimental group will receive ubiquinol capsules (200 mg/day during 2 weeks) and a control group receiving placebo during the same period of time. Likewise, a nutritional survey will be realized, with follow-up of 72h, to assure that the all the subjects consume similar diets and these will not interfere with the study. They will be informed about the characteristics of the study and we will get informed consent form them.
Following the EFSA Guides, the subjects might be considered to be a healthy population in general and inside this category, they are a specific group of physically active subjects, there would be included the normal population and / or amateur sportsman.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Ubiquinol 200mg/day (two capsules of 100 mg (Breakfast and lunch)) for 14 days
Other names: reduced Coenzyme Q10
placebo capsules (two capsules (Breakfast and lunch)) for 14 days
Other names: Capsules without ubiquinol
Time frame: May-June 2013 (1 month)
Oxidative stress and Inflammatory signaling and Muscle Function
Time frame: May-June 2013 (1 month)
physical performance, resitance , muscle function and weakening
Universidad de Granada
Other
Influence of a Short Term Supplementation With Ubiquinol on Diverse Aspects Related to the Physical Activity (Muscle Function, Oxidative Stress and Inflammatory Signaling)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04676958
Behavior, Exercise
Glasgow, United Kingdom
View Trial DetailsNCT03735186
Behavior, Cardiovascular Diseases
Loughborough, Leicestershire, United Kingdom
View Trial DetailsNCT07662954
Behavior, Echocardiography
Karaman, Turkey (Türkiye)
View Trial DetailsNCT07479940
Aging, Behavior
Ribeirão Preto, São Paulo, Brazil
View Trial Details